Cancer Biomarkers & Companion Diagnostics emphasizes the discovery, validation, and clinical application of biomarkers that support early detection, prognosis, treatment selection, and therapeutic monitoring. Companion diagnostics play a vital role in precision oncology by identifying patients most likely to benefit from targeted therapies and immunotherapies. This session welcomes research on molecular biomarkers, genomic profiling, predictive and prognostic markers, biomarker-driven clinical decision-making, and emerging diagnostic technologies that advance personalized cancer treatment.
Cancer Biomarkers Conference